Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:cerdam01

Total Results:

296


The role of prescription opioid and cannabis supply policies on opioid overdose deaths

Cerdá, Magdalena; Wheeler-Martin, Katherine; Bruzelius, Emilie; Mauro, Christine M; Crystal, Stephen; Davis, Corey S; Adhikari, Samrachana; Santaella-Tenorio, Julian; Keyes, Katherine M; Rudolph, Kara E; Hasin, Deborah; Martins, Silvia S
Mandatory prescription drug monitoring programs and cannabis legalization have been hypothesized to reduce overdose deaths. We examined associations between prescription monitoring programs with access mandates ("must-query PDMPs"), legalization of medical and recreational cannabis supply, and opioid overdose deaths in United States counties in 2013-2020. Using data on overdose deaths from the National Vital Statistics System, we fit Bayesian spatiotemporal models to estimate risk differences and 95% credible intervals (CrI) in county-level opioid overdose deaths associated with enactment of these state policies. Must-query PDMPs were independently associated with on average 0.8 (95% CrI: 0.5, 1.0) additional opioid-involved overdose deaths per 100,000 person-years. Legal cannabis supply was not independently associated with opioid overdose deaths in this time period. Must-query PDMPs enacted in the presence of legal (medical or recreational) cannabis supply were associated with 0.7 (95% CrI: 0.4, 0.9) more opioid-involved deaths, relative to must-query PDMPs without any legal cannabis supply. In a time when overdoses are driven mostly by non-prescribed opioids, stricter opioid prescribing policies and more expansive cannabis legalization were not associated with reduced overdose death rates.
PMID: 39030721
ISSN: 1476-6256
CID: 5732102

Demonstrating Agreement between Radio and Fluorescence Measurements of the Depth of Maximum of Extensive Air Showers at the Pierre Auger Observatory

Abdul Halim, A; Abreu, P; Aglietta, M; Allekotte, I; Cheminant, K Almeida; Almela, A; Aloisio, R; Alvarez-Muñiz, J; Yebra, J Ammerman; Anastasi, G A; Anchordoqui, L; Andrada, B; Andringa, S; Anukriti,; Apollonio, L; Aramo, C; Ferreira, P R Araújo; Arnone, E; Velázquez, J C Arteaga; Assis, P; Avila, G; Avocone, E; Bakalova, A; Barbato, F; Mocellin, A Bartz; Bellido, J A; Berat, C; Bertaina, M E; Bhatta, G; Bianciotto, M; Biermann, P L; Binet, V; Bismark, K; Bister, T; Biteau, J; Blazek, J; Bleve, C; Blümer, J; Boháčová, M; Boncioli, D; Bonifazi, C; Arbeletche, L Bonneau; Borodai, N; Brack, J; Orchera, P G Brichetto; Briechle, F L; Bueno, A; Buitink, S; Buscemi, M; Büsken, M; Bwembya, A; Caballero-Mora, K S; Cabana-Freire, S; Caccianiga, L; Caruso, R; Castellina, A; Catalani, F; Cataldi, G; Cazon, L; Cerda, M; Cermenati, A; Chinellato, J A; Chudoba, J; Chytka, L; Clay, R W; Cerutti, A C Cobos; Colalillo, R; Coleman, A; Coluccia, M R; Conceição, R; Condorelli, A; Consolati, G; Conte, M; Convenga, F; Dos Santos, D Correia; Costa, P J; Covault, C E; Cristinziani, M; Sanchez, C S Cruz; Dasso, S; Daumiller, K; Dawson, B R; de Almeida, R M; de Jesús, J; de Jong, S J; Neto, J R T de Mello; De Mitri, I; de Oliveira, J; Franco, D de Oliveira; de Palma, F; de Souza, V; de Errico, B P de Souza; De Vito, E; Del Popolo, A; Deligny, O; Denner, N; Deval, L; di Matteo, A; Dobre, M; Dobrigkeit, C; D'Olivo, J C; Mendes, L M Domingues; Dorosti, Q; Dos Anjos, J C; Dos Anjos, R C; Ebr, J; Ellwanger, F; Emam, M; Engel, R; Epicoco, I; Erdmann, M; Etchegoyen, A; Evoli, C; Falcke, H; Farmer, J; Farrar, G; Fauth, A C; Fazzini, N; Feldbusch, F; Fenu, F; Fernandes, A; Fick, B; Figueira, J M; Filipčič, A; Fitoussi, T; Flaggs, B; Fodran, T; Fujii, T; Fuster, A; Galea, C; Galelli, C; García, B; Gaudu, C; Gemmeke, H; Gesualdi, F; Gherghel-Lascu, A; Ghia, P L; Giaccari, U; Glombitza, J; Gobbi, F; Gollan, F; Golup, G; Berisso, M Gómez; Vitale, P F Gómez; Gongora, J P; González, J M; González, N; Goos, I; Góra, D; Gorgi, A; Gottowik, M; Grubb, T D; Guarino, F; Guedes, G P; Guido, E; Gülzow, L; Hahn, S; Hamal, P; Hampel, M R; Hansen, P; Harari, D; Harvey, V M; Haungs, A; Hebbeker, T; Hojvat, C; Hörandel, J R; Horvath, P; Hrabovský, M; Huege, T; Insolia, A; Isar, P G; Janecek, P; Jilek, V; Johnsen, J A; Jurysek, J; Kampert, K-H; Keilhauer, B; Khakurdikar, A; Covilakam, V V Kizakke; Klages, H O; Kleifges, M; Knapp, F; Köhler, J; Kunka, N; Lago, B L; Langner, N; de Oliveira, M A Leigui; Lema-Capeans, Y; Letessier-Selvon, A; Lhenry-Yvon, I; Lopes, L; Lu, L; Luce, Q; Lundquist, J P; Payeras, A Machado; Majercakova, M; Mandat, D; Manning, B C; Mantsch, P; Marafico, S; Mariani, F M; Mariazzi, A G; Mariş, I C; Marsella, G; Martello, D; Martinelli, S; Bravo, O Martínez; Martins, M A; Mathes, H-J; Matthews, J; Matthiae, G; Mayotte, E; Mayotte, S; Mazur, P O; Medina-Tanco, G; Meinert, J; Melo, D; Menshikov, A; Merx, C; Michal, S; Micheletti, M I; Miramonti, L; Mollerach, S; Montanet, F; Morejon, L; Morello, C; Mulrey, K; Mussa, R; Namasaka, W M; Negi, S; Nellen, L; Nguyen, K; Nicora, G; Niechciol, M; Nitz, D; Nosek, D; Novotny, V; Nožka, L; Nucita, A; Núñez, L A; Oliveira, C; Palatka, M; Pallotta, J; Panja, S; Parente, G; Paulsen, T; Pawlowsky, J; Pech, M; Pękala, J; Pelayo, R; Pereira, L A S; Martins, E E Pereira; Armand, J Perez; Bertolli, C Pérez; Perrone, L; Petrera, S; Petrucci, C; Pierog, T; Pimenta, M; Platino, M; Pont, B; Pothast, M; Shahvar, M Pourmohammad; Privitera, P; Prouza, M; Puyleart, A; Querchfeld, S; Rautenberg, J; Ravignani, D; Akim, J V Reginatto; Reininghaus, M; Ridky, J; Riehn, F; Risse, M; Rizi, V; de Carvalho, W Rodrigues; Rodriguez, E; Rojo, J Rodriguez; Roncoroni, M J; Rossoni, S; Roth, M; Roulet, E; Rovero, A C; Ruehl, P; Saftoiu, A; Saharan, M; Salamida, F; Salazar, H; Salina, G; Gomez, J D Sanabria; Sánchez, F; Santos, E M; Santos, E; Sarazin, F; Sarmento, R; Sato, R; Savina, P; Schäfer, C M; Scherini, V; Schieler, H; Schimassek, M; Schimp, M; Schmidt, D; Scholten, O; Schoorlemmer, H; Schovánek, P; Schröder, F G; Schulte, J; Schulz, T; Sciutto, S J; Scornavacche, M; Segreto, A; Sehgal, S; Shivashankara, S U; Sigl, G; Silli, G; Sima, O; Simkova, K; Simon, F; Smau, R; Šmída, R; Sommers, P; Soriano, J F; Squartini, R; Stadelmaier, M; Stanič, S; Stasielak, J; Stassi, P; Strähnz, S; Straub, M; Suomijärvi, T; Supanitsky, A D; Svozilikova, Z; Szadkowski, Z; Tairli, F; Tapia, A; Taricco, C; Timmermans, C; Tkachenko, O; Tobiska, P; Peixoto, C J Todero; Tomé, B; Torrès, Z; Travaini, A; Travnicek, P; Trimarelli, C; Tueros, M; Unger, M; Vaclavek, L; Vacula, M; Galicia, J F Valdés; Valore, L; Varela, E; Vásquez-Ramírez, A; Veberič, D; Ventura, C; Quispe, I D Vergara; Verzi, V; Vicha, J; Vink, J; Vorobiov, S; Watanabe, C; Watson, A A; Weindl, A; Wiencke, L; Wilczyński, H; Wittkowski, D; Wundheiler, B; Yue, B; Yushkov, A; Zapparrata, O; Zas, E; Zavrtanik, D; Zavrtanik, M; ,
We show, for the first time, radio measurements of the depth of shower maximum (X_{max}) of air showers induced by cosmic rays that are compared to measurements of the established fluorescence method at the same location. Using measurements at the Pierre Auger Observatory we show full compatibility between our radio and the previously published fluorescence dataset, and between a subset of air showers observed simultaneously with both radio and fluorescence techniques, a measurement setup unique to the Pierre Auger Observatory. Furthermore, we show radio X_{max} resolution as a function of energy and demonstrate the ability to make competitive high-resolution X_{max} measurements with even a sparse radio array. With this, we show that the radio technique is capable of cosmic-ray mass composition studies, both at Auger and at other experiments.
PMID: 38277596
ISSN: 1079-7114
CID: 5911672

Spatiotemporal analysis of the association between residential eviction and fatal overdose in Rhode Island

Skinner, Alexandra; Li, Yu; Jent, Victoria; Goedel, William C; Hallowell, Benjamin D; Allen, Bennett; Leifheit, Kathryn M; Cartus, Abigail R; Macmadu, Alexandria; Pratty, Claire; Samuels, Elizabeth A; Ahern, Jennifer; Cerdá, Magdalena; Marshall, Brandon Dl
OBJECTIVE/UNASSIGNED:Policy ramifications of the COVID-19 pandemic shape the concurrent housing and overdose crises in the USA. Housing insecurity is a known risk factor for overdose, yet how residential eviction may influence fatal overdose risk is understudied. We sought to evaluate the spatiotemporal relationship between neighbourhood-level residential eviction rates and overdose mortality in Rhode Island (RI) before and during a statewide eviction moratorium in response to COVID-19. METHODS/UNASSIGNED:We conducted an ecological study at the census tract level in RI (N=240) by modelling the association between quintiles of eviction rates and fatal overdose rates from 2016 to 2021. We applied a Bayesian spatiotemporal approach using an integrated nested Laplace approximation and adjusted for an a priori determined set of time-varying demographic and policy covariates. RESULTS/UNASSIGNED:Descriptively, we observed a direct, dose-response relationship between quintiles of eviction incidence rates over the full study period and fatal overdose. Prior to the implementation of a statewide eviction moratorium, census tracts in the highest eviction quintile had increased rates of overdose mortality, relative to those in the lowest quintile (posterior mean relative rate = 1.49, 95% credible interval: 1.05 to 2.13). Associations during the periods of eviction moratorium were non-significant. CONCLUSION/UNASSIGNED:This work highlights the neighbourhood-level relationship between residential eviction and fatal overdose risk in the absence of an eviction moratorium. Enhanced investment in eviction prevention policies, such as rent relief and limitations to the circumstances under which landlords can file for eviction, may complement harm reduction efforts to reduce neighbourhood-level overdose inequalities.
PMCID:11812863
PMID: 40018241
ISSN: 2753-4294
CID: 5801342

Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022

Gorfinkel, Lauren R; Malte, Carol A; Fink, David S; Mannes, Zachary L; Wall, Melanie M; Olfson, Mark; Livne, Ofir; Keyhani, Salomeh; Keyes, Katherine M; Martins, Silvia S; Cerdá, Magdalena; Gutkind, Sarah; Maynard, Charles C; Saxon, Andrew J; Simpson, Tracy; Gonsalves, Gregg; Lu, Haidong; McDowell, Yoanna; Hasin, Deborah S
IMPORTANCE/UNASSIGNED:Given the personal and social burdens of opioid use disorder (OUD), understanding time trends in OUD prevalence in large patient populations is key to planning prevention and treatment services. OBJECTIVE/UNASSIGNED:To examine trends in the prevalence of OUD from 2005 to 2022 overall and by age, sex, and race and ethnicity. DESIGN, SETTING, AND PARTICIPANTS/UNASSIGNED:This serial cross-sectional study included national Veterans Health Administration (VHA) electronic medical record data from the VHA Corporate Data Warehouse. Adult patients (age ≥18 years) with a current OUD diagnosis (using International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] and International Statistical Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes) who received outpatient care at VHA facilities from January 1, 2005, to December 31, 2022, were eligible for inclusion in the analysis. MAIN OUTCOMES AND MEASURES/UNASSIGNED:The main outcome was OUD diagnoses. To test for changes in prevalence of OUD over time, multivariable logistic regression models were run that included categorical study year and were adjusted for sex, race and ethnicity, and categorical age. RESULTS/UNASSIGNED:The final sample size ranged from 4 332 165 to 5 962 564 per year; most were men (89.3%-95.0%). Overall, the annual percentage of VHA patients diagnosed with OUD almost doubled from 2005 to 2017 (0.60% [95% CI, 0.60%-0.61%] to 1.16% [95% CI, 1.15%-1.17%]; adjusted difference, 0.55 [95% CI, 0.54-0.57] percentage points) and declined thereafter (2022: 0.97% [95% CI, 0.97%-0.98%]; adjusted difference from 2017 to 2022, -0.18 [95% CI, -0.19 to -0.17] percentage points). This trend was similar among men (0.64% [95% CI, 0.63%-0.64%] in 2005 vs 1.22% [95% CI, 1.21%-1.23%] in 2017 vs 1.03% [95% CI, 1.02%-1.04%] in 2022), women (0.34% [95% CI, 0.32%-0.36%] in 2005 vs 0.68% [95% CI, 0.66%-0.69%] in 2017 vs 0.53% [95% CI, 0.52%-0.55%] in 2022), those younger than 35 years (0.62% [95% CI, 0.59%-0.66%] in 2005 vs 2.22% [95% CI, 2.18%-2.26%] in 2017 vs 1.00% [95% CI, 0.97%-1.03%] in 2022), those aged 35 to 64 years (1.21% [95% CI, 1.19%-1.22%] in 2005 vs 1.80% [95% CI, 1.78%-1.82%] in 2017 vs 1.41% [95% CI, 1.39%-1.42%] in 2022), and non-Hispanic White patients (0.44% [95% CI, 0.43%-0.45%] in 2005 vs 1.28% [95% CI, 1.27%-1.29%] in 2017 vs 1.13% [95% CI, 1.11%-1.14%] in 2022). Among VHA patients aged 65 years or older, OUD diagnoses increased from 2005 to 2022 (0.06% [95% CI, 0.06%-0.06%] to 0.61% [95% CI, 0.60%-0.62%]), whereas among Hispanic or Latino and non-Hispanic Black patients, OUD diagnoses decreased from 2005 (0.93% [95% CI, 0.88%-0.97%] and 1.26% [95% CI, 1.23%-1.28%], respectively) to 2022 (0.61% [95% CI, 0.59%-0.63%] and 0.82% [95% CI, 0.80%-0.83%], respectively). CONCLUSIONS AND RELEVANCE/UNASSIGNED:This serial cross-sectional study of national VHA electronic health record data found that the prevalence of OUD diagnoses increased from 2005 to 2017, peaked in 2017, and declined thereafter, a trend primarily attributable to changes among non-Hispanic White patients and those younger than 65 years. Continued public health efforts aimed at recognizing, treating, and preventing OUD are warranted.
PMCID:11662256
PMID: 39705031
ISSN: 2574-3805
CID: 5764912

The US overdose crisis: the next administration needs to move beyond criminalisation to a comprehensive public health approach [Editorial]

Cerdá, Magdalena; Krawczyk, Noa
PMID: 39486839
ISSN: 1756-1833
CID: 5747382

Social and economic determinants of drug overdose deaths: a systematic review of spatial relationships

Fink, David S; Schleimer, Julia P; Keyes, Katherine M; Branas, Charles C; Cerdá, Magdalena; Gruenwald, Paul; Hasin, Deborah
PURPOSE/OBJECTIVE:To synthesize the available evidence on the extent to which area-level socioeconomic conditions are associated with drug overdose deaths in the United States. METHODS:We performed a systematic review (in MEDLINE, EMBASE, PsychINFO, Web of Science, EconLit) for papers published prior to July 2022. Eligible studies quantitatively estimated the association between an area-level measure of socioeconomic conditions and drug overdose deaths in the US, and were published in English. We assessed study quality using the Effective Public Health Practice Project Quality Assessment Tool. The protocol was preregistered at Prospero (CRD42019121317). RESULTS:We identified 28 studies that estimated area-level effects of socioeconomic conditions on drug overdose deaths in the US. Studies were scored as having moderate to serious risk of bias attributed to both confounding and in analysis. Socioeconomic conditions and drug overdose death rates were moderately associated, and this was a consistent finding across a large number of measures and differences in study designs (e.g., cross-sectional versus longitudinal), years of data analyzed, and primary unit of analysis (e.g., ZIP code, county, state). CONCLUSIONS:This review highlights the evidence for area-level socioeconomic conditions are an important factor underlying the geospatial distribution of drug overdose deaths in the US and the need to understand the mechanisms underlying these associations to inform future policy recommendations. The current evidence base suggests that, at least in the United States, employment, income, and poverty interventions may be effective targets for preventing drug overdose mortality rates.
PMCID:11178445
PMID: 38356082
ISSN: 1433-9285
CID: 5738412

A simple heuristic for allocating opioid settlement funding to reduce overdose mortality in the United States

Skinner, Alexandra; Nolen, Shayla; Cerdá, Magdalena; Rich, Josiah D; Marshall, Brandon D L
As resolution for opioid-related claims and litigation against pharmaceutical manufacturers and other stakeholders, state and local governments are newly eligible for millions of dollars of settlement funding to address the overdose crisis in the United States. To inform effective use of opioid settlement funds, we propose a simple framework that highlights the principal determinants of overdose mortality: the number of people at risk of overdose each year, the average annual number of overdoses per person at risk, and the average probability of death per overdose event. We assert that the annual number of overdose deaths is a function of these three determinants, all of which can be modified through public health intervention. Our proposed heuristic depicts how each of these drivers of drug-related mortality - and the corresponding interventions designed to address each term - operate both in isolation and in conjunction. We intend for this framework to be used by policymakers as a tool for identifying and evaluating public health interventions and funding priorities that will most effectively address the structural forces shaping the overdose crisis and reduce overdose deaths.
PMCID:11305910
PMID: 38940829
ISSN: 1097-9891
CID: 5730322

Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile

Bórquez, Ignacio; Cerdá, Magdalena; González-Santa Cruz, Andrés; Krawczyk, Noa; Castillo-Carniglia, Álvaro
BACKGROUND AND AIMS:Longitudinal studies have revealed that substance use treatment use is often recurrent among patients; the longitudinal patterns and characteristics of those treatment trajectories have received less attention, particularly in the global south. This study aimed to disentangle heterogeneity in treatment use among adult patients in Chile by identifying distinct treatment trajectory groups and factors associated with them. DESIGN:National-level registry-based retrospective cohort. SETTING AND PARTICIPANTS:Adults admitted to publicly funded substance use disorder treatment programs in Chile from November 2009 to November 2010 and followed for 9 years (n = 6266). MEASUREMENTS:Monthly treatment use; type of treatment; ownership of the treatment center; discharge status; primary substance used; sociodemographic. FINDINGS:A seven-class treatment trajectory solution was chosen using latent class growth analysis. We identified three trajectory groups that did not recur and had different treatment lengths: Early discontinuation (32%), Less than a year in treatment (19.7%) and Year-long episode, without recurrence (12.3%). We also identified a mixed trajectory group that had a long first treatment or two treatment episodes with a brief time between treatments: Long first treatment, or immediate recurrence (6.3%), and three recurrent treatment trajectory groups: Recurrent and decreasing (14.2%), Early discontinuation with recurrence (9.9%) and Recurrent after long between treatments period (5.7%). Inpatient or outpatient high intensity (vs. outpatient low intensity) at first entry increased the odds of being in the longer one-episode groups compared with the Early discontinuation group. Women had increased odds of belonging to all the recurrent groups. Using cocaine paste (vs. alcohol) as a primary substance decreased the odds of belonging to long one-episode groups. CONCLUSIONS:In Chile, people in publicly funded treatment for substance use disorder show seven distinct care trajectories: three groups with different treatment lengths and no recurring episodes, a mixed group with a long first treatment or two treatment episodes with a short between-treatment-episodes period and three recurrent treatment groups.
PMID: 38192124
ISSN: 1360-0443
CID: 5722952

Medicaid Expansion-An Important Policy Lever to Improve Health Among Justice-Involved Populations

Cerdá, Magdalena
PMID: 39287952
ISSN: 2574-3805
CID: 5720422

Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study

Henry, Stephen G; Fang, Shao-You; Crawford, Andrew J; Wintemute, Garen J; Tseregounis, Iraklis Erik; Gasper, James J; Shev, Aaron; Cartus, Abigail R; Marshall, Brandon D L; Tancredi, Daniel J; Cerdá, Magdalena; Stewart, Susan L
BACKGROUND:Both increases and decreases in patients' prescribed daily opioid dose have been linked to increased overdose risk, but associations between 30-day dose trajectories and subsequent overdose risk have not been systematically examined. OBJECTIVE:To examine the associations between 30-day prescribed opioid dose trajectories and fatal opioid overdose risk during the subsequent 15 days. DESIGN/METHODS:Statewide cohort study using linked prescription drug monitoring program and death certificate data. We constructed a multivariable Cox proportional hazards model that accounted for time-varying prescription-, prescriber-, and pharmacy-level factors. PARTICIPANTS/METHODS:All patients prescribed an opioid analgesic in California from March to December, 2013 (5,326,392 patients). MAIN MEASURES/METHODS:Dependent variable: fatal drug overdose involving opioids. Primary independent variable: a 16-level variable denoting all possible opioid dose trajectories using the following categories for current and 30-day previously prescribed daily dose: 0-29, 30-59, 60-89, or ≥90 milligram morphine equivalents (MME). KEY RESULTS/RESULTS:Relative to patients prescribed a stable daily dose of 0-29 MME, large (≥2 categories) dose increases and having a previous or current dose ≥60 MME per day were associated with significantly greater 15-day overdose risk. Patients whose dose decreased from ≥90 to 0-29 MME per day had significantly greater overdose risk compared to both patients prescribed a stable daily dose of ≥90 MME (aHR 3.56, 95%CI 2.24-5.67) and to patients prescribed a stable daily dose of 0-29 MME (aHR 7.87, 95%CI 5.49-11.28). Patients prescribed benzodiazepines also had significantly greater overdose risk; being prescribed Z-drugs, carisoprodol, or psychostimulants was not associated with overdose risk. CONCLUSIONS:Large (≥2 categories) 30-day dose increases and decreases were both associated with increased risk of fatal opioid overdose, particularly for patients taking ≥90 MME whose opioids were abruptly stopped. Results align with 2022 CDC guidelines that urge caution when reducing opioid doses for patients taking long-term opioid for chronic pain.
PMCID:10897080
PMID: 37794260
ISSN: 1525-1497
CID: 5707792